» Articles » PMID: 22264352

Proteomic Profiling of Pseudomonas Aeruginosa AES-1R, PAO1 and PA14 Reveals Potential Virulence Determinants Associated with a Transmissible Cystic Fibrosis-associated Strain

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2012 Jan 24
PMID 22264352
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pseudomonas aeruginosa is an opportunistic pathogen that is the major cause of morbidity and mortality in patients with cystic fibrosis (CF). While most CF patients are thought to acquire P. aeruginosa from the environment, person-person transmissible strains have been identified in CF clinics worldwide. The molecular basis for transmissibility and colonization of the CF lung remains poorly understood.

Results: A dual proteomics approach consisting of gel-based and gel-free comparisons were undertaken to analyse protein profiles in a transmissible, early (acute) isolate of the Australian epidemic strain 1 (AES-1R), the virulent burns/wound isolate PA14, and the poorly virulent, laboratory-associated strain PAO1. Over 1700 P. aeruginosa proteins were confidently identified. AES-1R protein profiles revealed elevated abundance of proteins associated with virulence and siderophore biosynthesis and acquisition, antibiotic resistance and lipopolysaccharide and fatty acid biosynthesis. The most abundant protein in AES-1R was confirmed as a previously hypothetical protein with sequence similarity to carbohydrate-binding proteins and database search revealed this gene is only found in the CF-associated strain PA2192. The link with CF infection may suggest that transmissible strains have acquired an ability to rapidly interact with host mucosal glycoproteins.

Conclusions: Our data suggest that AES-1R expresses higher levels of proteins, such as those involved in antibiotic resistance, iron acquisition and virulence that may provide a competitive advantage during early infection in the CF lung. Identification of novel proteins associated with transmissibility and acute infection may aid in deciphering new strategies for intervention to limit P. aeruginosa infections in CF patients.

Citing Articles

Modified -acyl-L-homoserine lactone compounds abrogate Las-dependent quorum-sensing response in human pathogen .

Ballante F, Turkina M, Ntzouni M, Magnusson K, Vikstrom E Front Mol Biosci. 2023; 10:1264773.

PMID: 37908228 PMC: 10613653. DOI: 10.3389/fmolb.2023.1264773.


Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria.

Browne K, Kuppusamy R, Walsh W, Black D, Willcox M, Kumar N Int J Mol Sci. 2023; 24(19).

PMID: 37834415 PMC: 10573972. DOI: 10.3390/ijms241914966.


The novel type II toxin-antitoxin PacTA modulates Pseudomonas aeruginosa iron homeostasis by obstructing the DNA-binding activity of Fur.

Song Y, Zhang S, Ye Z, Song Y, Chen L, Tong A Nucleic Acids Res. 2022; 50(18):10586-10600.

PMID: 36200834 PMC: 9561280. DOI: 10.1093/nar/gkac867.


Proteomic profiling of clinical and environmental strains of Pseudomonas aeruginosa.

Liew S, Puthucheary S, Rajasekaram G, Chai H, Chua K Mol Biol Rep. 2021; 48(3):2325-2333.

PMID: 33728559 DOI: 10.1007/s11033-021-06262-8.


From genotype to phenotype: adaptations of to the cystic fibrosis environment.

Camus L, Vandenesch F, Moreau K Microb Genom. 2021; 7(3).

PMID: 33529147 PMC: 8190622. DOI: 10.1099/mgen.0.000513.


References
1.
Lutter P, Meyer H, Langer M, Witthohn K, Dormeyer W, Sickmann A . Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis. 2001; 22(14):2888-97. DOI: 10.1002/1522-2683(200108)22:14<2888::AID-ELPS2888>3.0.CO;2-C. View

2.
McPhee J, Tamber S, Bains M, Maier E, Gellatly S, Lo A . The major outer membrane protein OprG of Pseudomonas aeruginosa contributes to cytotoxicity and forms an anaerobically regulated, cation-selective channel. FEMS Microbiol Lett. 2009; 296(2):241-7. DOI: 10.1111/j.1574-6968.2009.01651.x. View

3.
Ernst R, Yi E, Guo L, Lim K, Burns J, Hackett M . Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science. 1999; 286(5444):1561-5. DOI: 10.1126/science.286.5444.1561. View

4.
Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B . Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 2000; 44(3):710-2. PMC: 89751. DOI: 10.1128/AAC.44.3.710-712.2000. View

5.
Wainwright C, France M, ORourke P, Anuj S, Kidd T, Nissen M . Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax. 2009; 64(11):926-31. PMC: 2764123. DOI: 10.1136/thx.2008.112466. View